Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

作者: C. T. Guy , M. A. Webster , M. Schaller , T. J. Parsons , R. D. Cardiff

DOI: 10.1073/PNAS.89.22.10578

关键词:

摘要: Overexpression and amplification of the neu (c-erbB2, ERBB2) protooncogene have been implicated in development aggressive human breast cancer. To directly assess effect mammary gland-specific expression protooncogene, transgenic mice carrying unactivated under transcriptional control mouse tumor virus promoter/enhancer were established. By contrast to rapid progression observed several strains activated transgene, epithelium resulted focal tumors after long latency. The majority analyzed expressed elevated levels neu-encoded mRNA protein. was also associated with intrinsic tyrosine kinase activity de novo phosphorylation cellular proteins. Interestingly, many tumor-bearing developed secondary metastatic lung. These observations suggest that overexpression protein can induce disease

参考文章(29)
C. I. Bargmann, R. A. Weinberg, Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. The EMBO Journal. ,vol. 7, pp. 2043- 2052 ,(1988) , 10.1002/J.1460-2075.1988.TB03044.X
Robert Cardiff, P. Leder, W. Muller, E. Sinn, Transgenic oncogene mice. Tumor phenotype predicts genotype. American Journal of Pathology. ,vol. 139, pp. 495- 501 ,(1991)
M van de Vijver, R van de Bersselaar, P Devilee, C Cornelisse, J Peterse, R Nusse, Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Molecular and Cellular Biology. ,vol. 7, pp. 2019- 2023 ,(1987) , 10.1128/MCB.7.5.2019
J. Hanson, B. E. Krause, W. A. McBlain, K. D. Dietrich, N. Jamil, J. Danyluk, H. Jenkins, A. H. G. Paterson, A. W. Lees, M. C. Paterson, R. M. Fourney, D. J. Slamon, Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Research. ,vol. 51, pp. 556- 567 ,(1991)
Eric Sinn, William Muller, Paul Pattengale, Isidore Tepler, Racheal Wallace, Philip Leder, Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo Cell. ,vol. 49, pp. 465- 475 ,(1987) , 10.1016/0092-8674(87)90449-1
R. M. Hudziak, J. Schlessinger, A. Ullrich, Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 7159- 7163 ,(1987) , 10.1073/PNAS.84.20.7159
Jeffrey A. Drebin, Victoria C. Link, David F. Stern, Robert A. Weinberg, Mark I. Greene, Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell. ,vol. 41, pp. 695- 706 ,(1985) , 10.1016/S0092-8674(85)80050-7
WJ Gullick, SB Love, C Wright, DM Barnes, B Gusterson, AL Harris, DG Altman, c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes British Journal of Cancer. ,vol. 63, pp. 434- 438 ,(1991) , 10.1038/BJC.1991.100
P. Di Fiore, J. Pierce, M. Kraus, O Segatto, C. King, S. Aaronson, erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells Science. ,vol. 237, pp. 178- 182 ,(1987) , 10.1126/SCIENCE.2885917